MiR-146a facilitates replication of dengue virus by dampening interferon induction by targeting TRAF6

Journal of Infection

Volumn 67, Issue 4, 2013, Pages 329-341

  Wu, Siyu ^a,b   He, Li ^a,b   Li, Yuye ^a,b   Wang, Tinglong ^a,b   Feng, Lianqiang ^a,b   Jiang, Lifang ^a,b   Zhang, Ping ^a,b   Huang, Xi ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Dengue virus; Interferon; MicroRNA; Replication; TRAF6

Indexed keywords

BETA INTERFERON; INTERFERON RECEPTOR; INTERFERON RECEPTOR 1; INTERFERON RECEPTOR 2; MICRORNA 146A; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DENGUE VIRUS; DENGUE VIRUS 2; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; INTERFERON INDUCTION; INTERFERON PRODUCTION; MONOCYTE; NONHUMAN; NORTHERN BLOTTING; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VIRUS REPLICATION; WESTERN BLOTTING;

EID: 84883031896     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2013.05.003     Document Type: Article

References (52)

1. Halstead S.B. Dengue. Lancet 2007, 370:1644-1652.
2. Borden E.C., Sen G.C., Uze G., Silverman R.H., Ransohoff R.M., Foster G.R., et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 2007, 6:975-990.
3. Ank N., West H., Paludan S.R. IFN-lambda: novel antiviral cytokines. J Interferon Cytokine Res 2006, 26:373-379.
4. Diamond M.S., Roberts T.G., Edgil D., Lu B., Ernst J., Harris E. Modulation of dengue virus infection in human cells by alpha, beta, and gamma interferons. J Virol 2000, 74:4957-4966.
5. Robek M.D., Boyd B.S., Chisari F.V. Lambda interferon inhibits hepatitis B and C virus replication. J Virol 2005, 79:3851-3854.
6. Liang Z., Wu S., Li Y., He L., Wu M., Jiang L., et al. Activation of toll-like receptor 3 impairs the dengue virus serotype 2 replication through induction of IFN-beta in cultured hepatoma cells. PLoS One 2011, 6:e23346.
7. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 2008, 89:1-47.
8. Morrison J., Aguirre S., Fernandez-Sesma A. Innate immunity evasion by dengue virus. Viruses 2012, 4:397-413.
9. Hou J., Wang P., Lin L., Liu X., Ma F., An H., et al. MicroRNA-146a feedback inhibits RIG-I-dependent type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2. J Immunol 2009, 183:2150-2158.
10. Wang P., Hou J., Lin L., Wang C., Liu X., Li D., et al. Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. J Immunol 2010, 185:6226-6233.
11. Ambros V. The functions of animal microRNAs. Nature 2004, 431:350-355.
12. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
13. Bazzoni F., Rossato M., Fabbri M., Gaudiosi D., Mirolo M., Mori L., et al. Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc Natl Acad Sci U S A 2009, 106:5282-5287.
14. Case S.R., Martin R.J., Jiang D., Minor M.N., Chu H.W. MicroRNA-21 inhibits toll-like receptor 2 agonist-induced lung inflammation in mice. Exp Lung Res 2011, 37:500-508.
15. Monk C.E., Hutvagner G., Arthur J.S. Regulation of miRNA transcription in macrophages in response to Candida albicans. PLoS One 2010, 5:e13669.
16. Taganov K.D., Boldin M.P., Chang K.J., Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 2006, 103:12481-12486.
17. Gantier M.P. New perspectives in microRNA regulation of innate immunity. J Interferon Cytokine Res 2010, 30:283-289.
18. Tomita M., Tanaka Y., Mori N. MicroRNA miR-146a is induced by HTLV-1 tax and increases the growth of HTLV-1-infected T-cells. Int J Cancer 2009, 130:2300-2309.
19. Rom S., Rom I., Passiatore G., Pacifici M., Radhakrishnan S., Del Valle L., et al. CCL8/MCP-2 is a target for mir-146a in HIV-1-infected human microglial cells. FASEB J 2010, 24:2292-2300.
20. Motsch N., Pfuhl T., Mrazek J., Barth S., Grasser F.A. Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) induces the expression of the cellular microRNA miR-146a. RNA Biol 2007, 4:131-137.
21. Punj V., Matta H., Schamus S., Tamewitz A., Anyang B., Chaudhary P.M. Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a. Oncogene 2010, 29:1835-1844.
22. Lee T.C., Lin Y.L., Liao J.T., Su C.M., Lin C.C., Lin W.P., et al. Utilizing liver-specific microRNA-122 to modulate replication of dengue virus replicon. Biochem Biophys Res Commun 2010, 396:596-601.
23. Heiss B.L., Maximova O.A., Pletnev A.G. Insertion of microRNA targets into the flavivirus genome alters its highly neurovirulent phenotype. J Virol 2011, 85:1464-1472.
24. Pham A.M., Langlois R.A., TenOever B.R. Replication in cells of hematopoietic origin is necessary for dengue virus dissemination. PLoS Pathog 2012, 8:e1002465.
25. Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg 1938, 27:493-497.
26. Maul A. Aspects statistiques des méthodes de quantification en virologie. Virologie des milieux hydriques 1991, 143-171. Tec & Doc - Lavoisier.
27. Yoshida R., Takaesu G., Yoshida H., Okamoto F., Yoshioka T., Choi Y., et al. TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway. J Biol Chem 2008, 283:36211-36220.
28. Graff J.W., Dickson A.M., Clay G., McCaffrey A.P., Wilson M.E. Identifying functional microRNAs in macrophages with polarized phenotypes. J Biol Chem 2012, 287:21816-21825.
29. Lin Y.W., Wang K.J., Lei H.Y., Lin Y.S., Yeh T.M., Liu H.S., et al. Virus replication and cytokine production in dengue virus-infected human B lymphocytes. J Virol 2002, 76:12242-12249.
30. Rodriguez-Madoz J.R., Bernal-Rubio D., Kaminski D., Boyd K., Fernandez-Sesma A. Dengue virus inhibits the production of type I interferon in primary human dendritic cells. J Virol 2010, 84:4845-4850.
31. Zhang X., Zhang E., Ma Z., Pei R., Jiang M., Schlaak J.F., et al. Modulation of hepatitis B virus replication and hepatocyte differentiation by microRNA-1. Hepatology 2011, 53:1476-1485.
32. Ishida H., Tatsumi T., Hosui A., Nawa T., Kodama T., Shimizu S., et al. Alterations in microRNA expression profile in HCV-infected hepatoma cells: involvement of miR-491 in regulation of HCV replication via the PI3 kinase/Akt pathway. Biochem Biophys Res Commun 2011, 412:92-97.
33. Wilson J.A., Zhang C., Huys A., Richardson C.D. Human Ago2 is required for efficient microRNA 122 regulation of hepatitis C virus RNA accumulation and translation. J Virol 2011, 85:2342-2350.
34. Liu H., Song L., Huang W. MiR26a and miR939 regulate the replication of H1N1 influenza virus in MDCK cell. Wei Sheng Wu Xue Bao 2010, 50:1399-1405.
35. Zheng S.Q., Li Y.X., Zhang Y., Li X., Tang H. MiR-101 regulates HSV-1 replication by targeting ATP5B. Antiviral Res 2011, 89:219-226.
36. Hao M., Zheng S., Ding H., Huang A. Regulation of microRNA-122 on HBV replication by targeting HBx sequence. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2011, 28:784-789. 803.
37. Tang Y., Luo X., Cui H., Ni X., Yuan M., Guo Y., et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. Arthritis Rheum 2009, 60:1065-1075.
38. Yang K., He Y.S., Wang X.Q., Lu L., Chen Q.J., Liu J., et al. MiR-146a inhibits oxidized low-density lipoprotein-induced lipid accumulation and inflammatory response via targeting toll-like receptor 4. FEBS Lett 2011, 585:854-860.
39. Curtale G., Citarella F., Carissimi C., Goldoni M., Carucci N., Fulci V., et al. An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes. Blood 2010, 115:265-273.
40. Chen T., Li Z., Jing T., Zhu W., Ge J., Zheng X., et al. MicroRNA-146a regulates the maturation process and pro-inflammatory cytokine secretion by targeting CD40L in oxLDL-stimulated dendritic cells. FEBS Lett 2011, 585:567-573.
41. Mei J., Bachoo R., Zhang C.L. MicroRNA-146a inhibits glioma development by targeting Notch1. Mol Cell Biol 2011, 31:3584-3592.
42. Li J., Huang J., Dai L., Yu D., Chen Q., Zhang X., et al. miR-146a, an IL-1beta responsive miRNA, induces vascular endothelial growth factor and chondrocyte apoptosis by targeting Smad4. Arthritis Res Ther 2012, 14:R75.
43. Takeda K. Evolution and integration of innate immune recognition systems: the toll-like receptors. J Endotoxin Res 2005, 11:51-55.
44. Konno H., Yamamoto T., Yamazaki K., Gohda J., Akiyama T., Semba K., et al. TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA. PLoS One 2009, 4:e5674.
45. An H., Hou J., Zhou J., Zhao W., Xu H., Zheng Y., et al. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat Immunol 2008, 9:542-550.
46. Uematsu S., Sato S., Yamamoto M., Hirotani T., Kato H., Takeshita F., et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction. J Exp Med 2005, 201:915-923.
47. Shi C.S., Kehrl J.H. Traf6 and A20 differentially regulate TLR4-induced autophagy by affecting the ubiquitination of beclin 1. Autophagy 2010, 6:986-987.
48. Meng Q., Zheng M., Liu H., Song C., Zhang W., Yan J., et al. TRAF6 regulates proliferation, apoptosis, and invasion of osteosarcoma cell. Mol Cell Biochem 2012, 371:177-186.
49. Wang P.H., Wan D.H., Gu Z.H., Deng X.X., Weng S.P., Yu X.Q., et al. Litopenaeus vannamei tumor necrosis factor receptor-associated factor 6 (TRAF6) responds to Vibrio alginolyticus and white spot syndrome virus (WSSV) infection and activates antimicrobial peptide genes. Dev Comp Immunol 2011, 35:105-114.
50. Marianneau P., Flamand M., Deubel V., Despres P. Apoptotic cell death in response to dengue virus infection: the pathogenesis of dengue haemorrhagic fever revisited. Clin Diagn Virol 1998, 10:113-119.
51. Pan X., Zhou G., Wu J., Bian G., Lu P., Raikhel A.S., et al. Wolbachia induces reactive oxygen species (ROS)-dependent activation of the toll pathway to control dengue virus in the mosquito Aedes aegypti. Proc Natl Acad Sci U S A 2012, 109:E23-E31.
52. McLean J.E., Wudzinska A., Datan E., Quaglino D., Zakeri Z. Flavivirus NS4A-induced autophagy protects cells against death and enhances virus replication. J Biol Chem 2011, 286:22147-22159.